JP2023143940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023143940A5 JP2023143940A5 JP2023119151A JP2023119151A JP2023143940A5 JP 2023143940 A5 JP2023143940 A5 JP 2023143940A5 JP 2023119151 A JP2023119151 A JP 2023119151A JP 2023119151 A JP2023119151 A JP 2023119151A JP 2023143940 A5 JP2023143940 A5 JP 2023143940A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharma
- subject
- combination
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762501696P | 2017-05-04 | 2017-05-04 | |
| US62/501,696 | 2017-05-04 | ||
| USPCT/US2017/048748 | 2017-08-25 | ||
| PCT/US2017/048748 WO2018039642A1 (en) | 2016-08-26 | 2017-08-25 | Compositions and methods thereof |
| TW106129169A TW201815387A (zh) | 2016-08-26 | 2017-08-28 | 組成物及其方法 |
| TW106129169 | 2017-08-28 | ||
| US201862634162P | 2018-02-22 | 2018-02-22 | |
| US62/634,162 | 2018-02-22 | ||
| US201862636099P | 2018-02-27 | 2018-02-27 | |
| US201862635554P | 2018-02-27 | 2018-02-27 | |
| US62/635,554 | 2018-02-27 | ||
| US62/636,099 | 2018-02-27 | ||
| US201862636171P | 2018-02-28 | 2018-02-28 | |
| US62/636,171 | 2018-02-28 | ||
| PCT/US2018/030978 WO2018204713A1 (en) | 2017-05-04 | 2018-05-03 | Targeted drug rescue with novel compositions, combinations, and methods thereof |
| JP2019560216A JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560216A Division JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023143940A JP2023143940A (ja) | 2023-10-06 |
| JP2023143940A5 true JP2023143940A5 (enrdf_load_stackoverflow) | 2024-10-04 |
Family
ID=65431106
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560216A Active JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
| JP2023119151A Pending JP2023143940A (ja) | 2017-05-04 | 2023-07-21 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560216A Active JP7514078B2 (ja) | 2017-05-04 | 2018-05-03 | 新規な組成物、組み合わせ及びその方法を用いた標的薬物救済 |
Country Status (13)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018204713A1 (en) * | 2017-05-04 | 2018-11-08 | Exciva Ug (Haftungsbeschränkt) | Targeted drug rescue with novel compositions, combinations, and methods thereof |
| BR112021018564A2 (pt) * | 2019-03-18 | 2021-11-30 | Avanir Pharmaceuticals Inc | Métodos de tratamento de sintomas negativos de esquizofrenia usando dextrometorfano deuterado e quinidina |
| JP7400818B2 (ja) * | 2019-06-06 | 2023-12-19 | Jsr株式会社 | 感放射線性樹脂組成物、レジストパターン形成方法及び化合物 |
| CA3177454A1 (en) | 2020-05-19 | 2021-11-25 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| CN116473077B (zh) * | 2023-05-08 | 2025-04-11 | 广东方中高新材料有限公司 | 一种n,n配位的镓配合物抗菌剂的合成和应用 |
| CN116473073A (zh) * | 2023-05-08 | 2023-07-25 | 广东方中高新材料有限公司 | 一种含镓配合物的吡唑醚菌酯增效悬浮制剂及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4241065A (en) * | 1979-07-02 | 1980-12-23 | E. I. Du Pont De Nemours And Company | Fluoro analogs of hydrocodone and oxycodone useful as analgesics, narcotic antagonists or both |
| US4950658A (en) * | 1988-12-06 | 1990-08-21 | Board Of Trustees Of Southern Illinois Univ. | Method of medical treatment of Alzheimer's disease |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US6207674B1 (en) * | 1999-12-22 | 2001-03-27 | Richard A. Smith | Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| US6335371B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Method for inducing cognition enhancement |
| TWI326214B (en) | 2002-07-17 | 2010-06-21 | Avanir Pharmaceuticals Inc | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| US20070099947A1 (en) * | 2005-11-03 | 2007-05-03 | Alkermes, Inc. | Methods and compositions for the treatment of brain reward system disorders by combination therapy |
| KR20080097443A (ko) | 2006-02-03 | 2008-11-05 | 아바니르 파마슈티컬스 | 덱스트로메토판 및 퀴니딘을 포함하는, 우울, 불안 및 신경퇴행성 장애 치료용 약제학적 조성물 |
| NZ582124A (en) * | 2007-05-21 | 2012-07-27 | Reviva Pharmaceuticals Inc | Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents |
| US8017623B2 (en) * | 2008-07-03 | 2011-09-13 | Trinity Laboratories, Inc. | Dextromethorphan hydrochloride |
| US9737531B2 (en) * | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| CA2903757A1 (en) * | 2013-03-07 | 2014-09-12 | Mindlab LLC | Pain medicine combination and uses thereof |
| JP2016516202A (ja) * | 2013-03-15 | 2016-06-02 | キネメッド， インコーポレイテッド | バイオマーカー |
| EP3708168A3 (en) * | 2014-09-14 | 2020-12-09 | Avanir Pharmaceuticals, Inc. | Combinations of deuterated dextromethorphan and quinidine for the treatment of agitation in dementia |
| RU2764716C2 (ru) * | 2016-08-26 | 2022-01-19 | Экссива Уг (Хафтунгзбешрэнкт) | Композиции и связанные с ними способы |
| WO2018204713A1 (en) * | 2017-05-04 | 2018-11-08 | Exciva Ug (Haftungsbeschränkt) | Targeted drug rescue with novel compositions, combinations, and methods thereof |
-
2018
- 2018-05-03 WO PCT/US2018/030978 patent/WO2018204713A1/en active Application Filing
- 2018-05-03 MA MA049464A patent/MA49464A/fr unknown
- 2018-05-03 KR KR1020217033764A patent/KR102444803B1/ko active Active
- 2018-05-03 BR BR112019022902A patent/BR112019022902A2/pt not_active Application Discontinuation
- 2018-05-03 CA CA3062452A patent/CA3062452C/en active Active
- 2018-05-03 KR KR1020197035796A patent/KR20200062078A/ko not_active Ceased
- 2018-05-03 JP JP2019560216A patent/JP7514078B2/ja active Active
- 2018-05-03 CA CA3138116A patent/CA3138116A1/en active Pending
- 2018-05-03 AU AU2018261654A patent/AU2018261654A1/en not_active Abandoned
- 2018-05-03 EP EP18794381.6A patent/EP3618819A4/en active Pending
- 2018-05-03 CN CN201880037396.3A patent/CN110831584B/zh active Active
- 2018-05-03 RU RU2019137004A patent/RU2760558C9/ru active
- 2018-05-04 TW TW107115320A patent/TWI787260B/zh active
-
2019
- 2019-10-31 IL IL270326A patent/IL270326B2/en unknown
- 2019-12-02 ZA ZA2019/08006A patent/ZA201908006B/en unknown
-
2021
- 2021-08-13 AU AU2021215274A patent/AU2021215274B2/en active Active
-
2023
- 2023-07-21 JP JP2023119151A patent/JP2023143940A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023143940A5 (enrdf_load_stackoverflow) | ||
| JP2008538741A (ja) | 鬱病の治療用及び／又は予防用の医薬組成物 | |
| JP6406713B2 (ja) | 低用量薬剤によるうつ病および他の疾患の処置 | |
| AU2007247480B2 (en) | Pharmaceutical combination comprising 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and an NSAID | |
| JP2004526788A5 (enrdf_load_stackoverflow) | ||
| JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
| JP2014062126A5 (enrdf_load_stackoverflow) | ||
| JP2018518537A5 (enrdf_load_stackoverflow) | ||
| JP2009541443A5 (enrdf_load_stackoverflow) | ||
| ZA200106890B (en) | Monoamine reuptake inhibitors for treatment of CNS disorders. | |
| JP2002226401A (ja) | うつ病の併用療法 | |
| RU2404771C3 (ru) | Комбинации, содержащие антимускариновые средства и бета-адренергические агонисты | |
| JP2009527525A (ja) | 尿失禁治療用のベンゾイミダゾロン誘導体 | |
| JP2008521827A5 (enrdf_load_stackoverflow) | ||
| JP2002515435A (ja) | 鬱病処置のための組合せ治療 | |
| JP6336592B2 (ja) | ヒスタミンｈ４受容体を介してもたらされた掻痒状態を治療するための医薬組成物 | |
| US20170151197A1 (en) | Lauflumide and the enantiomers thereof, method for preparing same and therapeutic uses thereof | |
| JP2021530488A (ja) | 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール | |
| MXPA02004410A (es) | Tratamiento de combinacion para la ansiedad y la depresion. | |
| JP7208139B2 (ja) | 双極性障害の予防、軽減又は治療のためのカルバメート化合物の使用 | |
| RU2010147881A (ru) | ФАРМАЦЕВТИЧЕСКИЙ ПРОДУКТ, СОДЕРЖАЩИЙ АНТАГОНИСТ МУСКАРИНОВОГО РЕЦЕПТОРА И АГОНИСТ β2-АДРЕНОРЕЦЕПТОРА | |
| RU2011105463A (ru) | ФАРМАЦЕВТИЧЕСКИЙ ПРОДУКТ, СОДЕРЖАЩИЙ АНТАГОНИСТ МУСКАРИНОВОГО РЕЦЕПТОРА И АГОНИСТ β2-АДРЕНОРЕЦЕПТОРА | |
| JP2015510893A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| US20020147206A1 (en) | Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy | |
| JP2005533791A5 (enrdf_load_stackoverflow) |